Study to investigate the most appropriate dose of posaconazole delayed release tablets, in the prophylaxis of fungal infection in patients after lung transplant.

Trial Profile

Study to investigate the most appropriate dose of posaconazole delayed release tablets, in the prophylaxis of fungal infection in patients after lung transplant.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2015

At a glance

  • Drugs Posaconazole (Primary)
  • Indications Mycoses
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 07 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top